Personal opinion - Please continue posting. I find your posts helpful. Ppl trash me as well for the opinions they do not agrree with. Buy I say to H*** with them.
There are some things that are not 100% clear. Shares outstanding could be preferred as well as common. I may have mis-read the PR thinking that was o/s which inherently refers to common stock.
If I referred you to the '14' I'm not sure why you would take offense. I recall you having questions about the preferred structure and conversion rate. It was impossible to explain on a post the chart in the 14 showing the entire structure was the only way to make sense of the old share structure.
As I kept saying pref shares were alphabet soup in the old structure. A-E all having different conversion rates and now everything is 1:1 unless I see something different.
B.O.Ds hold ~13M in voting rights so once outstanding reaches 26M+ they lose controlling stake. a/s is 110M so I'm not sure how they will expand much further than that safely. Either an equity partner or a merger as they've done in the past of trading shares for labs.
PalliaTech has given up 2 labs so far. One in CO and one in MA. I wonder if there will be a partnership or even a full merger there.
EVIO is exploring cannabis plant science and genetic research opportunities, and considering opportunities in legal cannabis marketplaces around the world.